TABLE 1.
Characteristics of the patient cohort
| Parametera | Valueb |
|---|---|
| Total patients (no.) | 179 |
| Age (yr) | |
| Average | 42 |
| Range | 22-70 |
| Sex (no. of females/no. of males) | 15/164 |
| Ethnicity | |
| Caucasian | 161 (90.0) |
| Other | 13 (7.3) |
| Unknown | 5 (2.7) |
| Risk code | |
| Homosexual | 99 (55.3) |
| Heterosexual | 12 (6.7) |
| i.v. drug abuse | 12 (6.7) |
| Residency in region of epidemicity | 3 (1.7) |
| Exposure to blood products | 1 (0.5) |
| Hemophilia | 40 (22.3) |
| Unknown | 12 (6.7) |
| HIV-1 viral subtype | |
| B | 179 (100) |
| Chronic HCV infection | 55 (30.7) |
| HCV genotype | |
| 1 | 29 (16.2) |
| 2 | 8 (4.5) |
| 3 | 10 (5.6) |
| 4 | 2 (1.1) |
| Multiple | 1 (0.5) |
| Unknown | 5 (2.7) |
| HBV status | |
| HBs+ | 15 (8.4) |
| Anti-HBs−, anti-HBc+ | 23 (12.8) |
| Anti-HBs+, Anti-HBc+ | 45 (25.1) |
| Anti-HIV therapy status | |
| Naive | 14 (7.8) |
| ART (<3 antiviral drugs) | 18 (10.1) |
| HAART (≥3 antiviral drugs) | 147 (82.1) |
a
i.v., intravenous; ART, antiretroviral therapy.
b
Unless otherwise indicated, values are numbers (percentages) of patients.